ISOXSUPRINE HYDROCHLORIDE by is a Prescription medication manufactured, distributed, or labeled by BI-COASTAL PHARMA INTERNATIONAL LIMITED LIABILITY COMPANY. Drug facts, warnings, and ingredients follow.
Based on a review of this drug by the National Academy of Sciences-National Research and/or other information, the FDA has classified the indications as follows:
Final classification of the less-than-effective indications requires further investigation.
On rare occasion oral administration of the drug has been associated in time with the occurrence of hypotension, tachycardia, chest pain, nausea, vomiting, dizziness, abdominal distress, and severe rash. If rash appears, the drug should be discontinued.
Although available evidence suggests a temporal association of these reactions with Isoxsuprine Hydrochloride, a causal relationship can be neither confirmed nor refuted.
Beta Adrenergic receptor stimulants such as Isoxsuprine Hydrocholoride have been used to inhibit pre-term labor.
Maternal and fetal tachycardia may occur under such use. Hypocalcemia, hypoglycemia, hypotension and ileus have been reported to occur in infants whose mothers received Isoxsuprine Hydrochloride. Pulmonary edema has been reported in mothers treated with beta stimulants. Isoxsuprine Hydrochloride is neither approved nor recommended for use in the treatment of premature labor.
Isoxsuprine HCl tablets, USP 10 mg
Bottles of 100 NDC: 42582-101-10
Isoxsuprine HCl tablets, USP 20 mg
Bottles of 1000 NDC: 42582-201-20
Isoxsuprine HCl tablets, USP 20 mg
Bottles of 100 NDC: 42582-201-10
Bi-Coastal Pharma International LLC
NDC: 42582-101-10
Isoxsuprine
Hydrochloride
Tablets, USP
10 mg
Rx only
100 Tablets
Bi-Coastal Pharma International LLC
NDC: 42582-201-10
Isoxsuprine
Hydrochloride
Tablets, USP
20 mg
Rx only
100 Tablets
ISOXSUPRINE HYDROCHLORIDE
isoxsuprine hydrochloride tablet |
||||||||||||||||||
|
||||||||||||||||||
|
||||||||||||||||||
|
||||||||||||||||||
|
||||||||||||||||||
|
||||||||||||||||||
|
ISOXSUPRINE HYDROCHLORIDE
isoxsuprine hydrochloride tablet |
||||||||||||||||||||
|
||||||||||||||||||||
|
||||||||||||||||||||
|
||||||||||||||||||||
|
||||||||||||||||||||
|
||||||||||||||||||||
|
Labeler - BI-COASTAL PHARMA INTERNATIONAL LIMITED LIABILITY COMPANY (078397428) |